Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-18 Sale |
2024-07-19 5:30 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
2,743 | $62 | $170,066 | 706,272 (Indirect Direct) |
View |
| 2024-07-15 Sale |
2024-07-17 7:07 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
47,257 | $63.73 | $3,011,592 | 709,015 (Indirect Direct) |
View |
| 2024-06-21 Sale |
2024-06-24 4:12 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
20,000 | $58.9 | $1,178,000 | 756,272 (Indirect Direct) |
View |
| 2024-06-17 Sale |
2024-06-20 7:11 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
30,000 | $60.59 | $1,817,663 | 776,272 (Indirect Direct) |
View |
| 2024-05-20 Sale |
2024-05-21 5:21 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
12,855 | $61.81 | $794,568 | 806,272 (Indirect Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 6:05 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
37,145 | $64.37 | $2,391,121 | 819,127 (Indirect Direct) |
View |
| 2024-04-18 Sale |
2024-04-22 6:26 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
27,232 | $65.1 | $1,772,729 | 856,272 (Indirect Direct) |
View |
| 2024-04-15 Sale |
2024-04-17 4:33 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
22,768 | $65.91 | $1,500,589 | 883,504 (Indirect Direct) |
View |
| 2024-03-08 Sale |
2024-03-11 6:43 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
10,000 | $67.17 | $671,700 | 906,272 (Indirect Direct) |
View |
| 2024-03-05 Sale |
2024-03-07 9:11 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
40,000 | $65.77 | $2,630,864 | 916,272 (Indirect Direct) |
View |
| 2024-01-19 Sale |
2024-01-23 5:32 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
25,216 | $56.17 | $1,416,466 | 935,027 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 6:20 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
24,784 | $55.29 | $1,370,305 | 960,243 (Indirect Direct) |
View |
| 2023-12-15 Sale |
2023-12-19 5:44 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
50,000 | $52.55 | $2,627,250 | 985,027 (Indirect Direct) |
View |
| 2023-11-17 Sale |
2023-11-20 9:05 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
13,000 | $51 | $663,000 | 1,035,027 (Indirect Direct) |
View |
| 2023-11-14 Sale(A) |
2023-11-20 8:58 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
37,000 | $53 | $1,961,148 | 995,620 (Indirect) |
View |
| 2023-11-14 Sale |
2023-11-16 6:11 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
36,190 | $53 | $1,918,080 | 1,048,837 (Indirect Direct) |
View |
| 2023-10-17 Sale |
2023-10-19 4:28 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
25,000 | $57.75 | $1,443,869 | 1,085,027 (Indirect Direct) |
View |
| 2023-10-13 Sale |
2023-10-17 4:32 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
25,000 | $57.96 | $1,449,036 | 1,110,027 (Indirect Direct) |
View |
| 2023-09-15 Sale |
2023-09-19 5:14 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
50,000 | $61.81 | $3,090,617 | 1,135,027 (Indirect Direct) |
View |
| 2023-08-28 Sale |
2023-08-30 4:29 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
50,000 | $63.22 | $3,160,750 | 1,185,027 (Indirect Direct) |
View |
| 2023-08-14 Sale |
2023-08-16 7:07 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
50,000 | $61.35 | $3,067,450 | 1,235,027 (Indirect Direct) |
View |
| 2023-07-19 Sale |
2023-07-21 7:15 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
23,469 | $52.02 | $1,220,844 | 1,285,027 (Indirect Direct) |
View |
| 2023-07-14 Sale |
2023-07-18 8:06 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
26,531 | $51.02 | $1,353,599 | 1,308,496 (Indirect Direct) |
View |
| 2023-06-20 Sale(A) |
2023-06-23 8:01 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
50,000 | $51.7 | $2,584,912 | 1,335,027 (Indirect Direct) |
View |
| 2023-06-20 Sale |
2023-06-22 8:00 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
40,000 | $51.75 | $2,070,012 | 1,345,027 (Indirect Direct) |
View |
| 2022-03-17 Purchase |
2022-03-21 9:58 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
10,000 | $27.65 | $276,503 | 1,356,080 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-12 Option Award |
2025-02-18 8:19 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
23,936 | $0 | 730,208 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-01 5:18 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
1,122 | $67.67 | 956,272 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:53 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
22,367 | $0 | 957,394 (Direct) |
View |
| 2023-02-28 Option Award |
2023-04-04 8:08 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
28,947 | $0 | 1,385,027 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 4:46 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
1,346,080 | $0 | 1,346,080 (Direct) |
View |